Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers
NCT: NCT07802119 · NOT_YET_RECRUITING
Brief Summary
This study is a prospective, single-arm, single-center feasibility study evaluating the safety and feasibility of transjugular (internal jugular vein) implantation of the Aveir VR leadless ventricular pacemaker in patients requiring ventricular pacing. A total of 15 patients will be enrolled at Xijing Hospital. The primary objective is to assess procedural feasibility and acute safety (from intraoperative to 48 hours post-procedure). Secondary objectives include short-term (1 to 3 months) pacing parameter stability (threshold, R-wave amplitude, impedance), technical success rate, procedure-related metrics, and adverse event rates.
Frequently Asked Questions
What is Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers?
Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers is a clinical trial registered under NCT07802119. Current status: NOT_YET_RECRUITING.
What is the status of NCT07802119?
The current status of NCT07802119 (Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers) is: NOT_YET_RECRUITING.
When did Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers start?
Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers started on 2026-09-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.